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block the action of more cytotoxic antibodies. The 
ability to elicit these blocking antibodies would be 
of obvious importance in transplantation, and this 
technique holds much promise. 
The second general way in which antibodies 
could act as immunosuppressants would be by 
feedback inhibition. One can inhibit the response 
to any antigen by passively immunizing the ani-
mal with antiserum. The most striking practical 
use of this phenomenon is seen in the prevention of 
erythroblastosis fetalis in children by the adminis-
tration of anti-Rh antiserum to the pregnant 
mother. Here, the administration of the antibody 
inhibits the immune response to the fetal Rh 
antigen. This technique has been applied to experi-
mental graft rejection with encouraging results. 
More must be learned about blocking antibody 
and the mechanism of feedback inhibition of anti-
body synthesis. The distinction between these two 
methods of suppression is not always clear but 
they promise clinical applicability. 
Immunosuppression by Specific Antigen 
An animal injected with a specific antigen may 
either be stimulated to produce an immune re-
sponse, or alternatively, develop an unresponsive 
state to subsequent exposure to the same antigen. 
This immunologically unresponsive state has been 
called "immunologic tolerance." It is specific for 
the antigen and differs from nonspecific immuno-
suppression in that it is antigen-directed. The 
best example of antigen-directed immunologic un-
responsiveness is the unresponsive state enjoyed 
by animals to their own body constituents. During 
early life, before maturation of the immune mech-
anisms, animals apparently develop an immuno-
logically unresponsive state to their own body 
constituents which is usually maintained through-
out life. This unresponsive state appears to result 
from direct contact between the "self' components 
and the antigen-reactive cells. Following Burnet's 
prediction that specific unresponsiveness could be 
induced to antigenic material by injection during 
early life, Billingham, Brent, and Medawar dem-
onstrated the induction of immunologic unrespon-
siveness in mice to histocompatibility antigens by 
the neonatal injection of replicating allogenic 
cells. Numerous investigators have since shown 
that immunologic unresponsiveness can be in-
duced to a variety of nonliving substances, as well 
as living cells, by injecting these substances into 
neonatal animals, or, under selected conditions, 
into adult animals. 
The conditions for producing immunologic un-
responsiveness directed against foreign antigens 
are complex; the dose of antigen given must be 
carefully chosen. In appears that the maintenance 
of a critical concentration of antigen throughout 
all the tissue fluids is more important than the 
amount initially injected. The age of the recipient 
or the status of his immunologic competence is 
also important. Neonatal animals are more likely 
to develop immunologic unresponsiveness to an 
antigen than adult animals. 
Certain antigens (like serum proteins) are en-
dowed with properties that are particularly favor-
able for the induction of immunologic unrespon-
siveness, i.e., the ability to persist in the circula-
tion and equilibrate within the extravascular 
spaces, thereby coming in contact with alltigen-
reactive cells in effective concentration. Viral and 
bacterial antigens and transplantation antigens 
do not have these properties and, in addition, may 
possess multiple antigenic specificities. The condi-
tions for the induction of tolerance to one spe-
cificity may not be conducive to the induction of 
tolerance to others on the same macromolecule. 
As a result, only a hyporesponsive state of short 
duration can usually be induced to these antigens. 
A diminished response to transplantation 
antigens can be induced in adult animals, however, 
but the antigen dose, physical state of the antigen, 
route of injection, and state of immunologic com-
petence must be carefully chosen to avoid immuni-
zation rather than the induction of tolerance. 
Irradiation, chemical immunosuppression, and 
antilymphocyte globulins have been used to inhibit 
the immune response and permit a relative un-
responsive state to develop to an antigen adminis-
tered while immunocompetence is depressed. 
It is likely that clinical transplantation de-
pends, even for its present success, on the estab-
lishment of a degree of immunologic unresponsive-
ness to the antigens implanted in the form of the 
transplanted organ. It is far easier to establish 
immunologic unresponsiveness to a vascularized 
organ graft than it is to an implanted graft such 
as a skin graft. In experimental situations the 
route of an antigen injection is likewise very im-
portant, the intravenous route being the most 
tolerogenic. 
The ultimate solution to the organ transplanta-
tion problem probably lies in immunologic in-
vestigation that will result in permitting the 
establishment of a permanent and specific im-
munologically unresponsive state to histocompati-
bility antigens. Histocompatibility typing must 
first be perfected so that the proper choice of his to-
compatibility antigen present in the donor, but 
absent in the recipient, can be made. The "weaker" 
the antigen, the easier it is to induce tolerance. 
The unresponsive state could then be induced by 
injecting pure soluble unaggregated histocompati-
bility antigens under conditions of generalized 
immunosuppression. The purity, proper physical 
state, dose, and timing have not been worked out, 
however. 
It is possible that immunologic unresponsive-
ness (tolerance) truly represents a specific nega-
tive response to an antigen but the state of rela-
tive unresponsiveness is more likely due to the 
presence of an antibody that itself interferes with 
the further development of immunity. Immuno-
suppression by antibody and immunosuppression 
by antigen may, therefore, be essentially identical 
mechanisms of specific immunosuppression. The 
presence of such antibodies cannot always be 
detected in "tolerant" individuals, but antibodies 
can be detected in patients with excellent long-
term functioning human renal allografts. Graft 
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function is thought to be prolonged by the pres-
ence of a specific antibody that inhibits the de-
velopment of truly effective antigraft immunity. 
This would explain the common finding in clinical 
transplantation that reduction in doses of im-
munosuppressive agents leads to the rejection of 
the graft despite apparent immunologic unre-
sponsiveness to the graft itself in the presence of 
very small amounts of chemical immunosup-
pressants. 
Whatever the mechanism of adaptation an 
organ allograft makes within its immunosup-
pressed host, the success of clinical transplanta-
tion requires a degree of immunologic unrespon-
siveness to the grafted organ. Otherwise, the 
doses of immunosuppressants necessary would be 
so high that patients would fall prey to any 
passing organism. 
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Liver Homotransplantation 
Thomas E. Starzl, M.D., Ph.D., and Charles W. Putnam, M.D. 
Treatment of terminal liver disease by trans-
plantation was founded on the encouragement and 
knowledge provided by the steadily improving 
experience in renal transplantation.21,23 However, 
the liver is a far more complicated organ, and its 
malfunction leads to vastly more complex phys-
iologic derangements. Liver patients are further 
handicapped, as are heart patients, by the lack of a 
satisfactory means of artificial support comparable 
to renal dialysis that could take over the organ's 
compromised functions during the wait for a 
suitable donor, or over the critical immediate post-
operative period. The transplanted liver must 
function efficiently practically from the moment of 
anastomosis or the patient is lost. 
Despite these and other difficulties, there has 
been enough progress in the laboratory and clinic 
to state that liver transplantation is now a feasi-
ble and legitimate, although imperfect, form of 
therapy, and one that may in certain cases be 
considered the treatment of choice. Human survi-
vals up to 23/4 years have been achieved. A great 
deal has been and is being learned at a pace that 
suggests that liver transplants will soon have at 
least as much chance to succeed as kidney grafts 
now have. 
KINDS OF LIVER TRANSPLANTATION 
There are two general approaches to transplant-
ation of the liver. With the first method, the host 
liver is removed and replaced with a homograft 
(orthotopic homotransplantation), The alternative 
technique is the insertion of an extra liver (auxil-
iary homotransplantation) at an ectopic site. Both 
procedures were developed in dogs and later 
studied in other species including rats, pigs, mon-
keys, and humans. The most encouraging results 
have been with orthotopic transplantation, for 
which reason most of this chapter will be con-
cerned primarily with this replacement operation. 
However, in a special section near the end of the 
chapter, auxiliary hepatic transplantation also 
will be briefly considered. 
IMMUNOLOGIC CONSIDERATIONS 
Is the Liver a Privileged Graft? 
When research in liver transplantation was in 
its early stages, it was suggested by Cannon' that 
if the liver played a significant role in graft rejec-
tion, hepatic homografts might enjoy a better fate 
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than other transplants because presumably the 
grafted liver would not participate in its own 
repudiation. The case for this rather mystical view 
even seemed strengthened by certain experiences 
with laboratory animals. When immunosuppres-
sion in canine recipients was stopped after 4 
months, a surprising number of animals continued 
to thrive either with no signs of rejection or with 
rejection episodes that waxed and waned remit-
tently.23.24 One such dog is still alive in our labora-
tory with stable liver function 7 years after the 
transplant. This phenomenon of "graft acceptance" 
had been noted in dogs with renal transplants2!' 2:; 
but less frequently. 
If the liver thus seemed to be an immunologically 
favored organ for transplantation in dogs, its 
status in pigs as observed by Garnier,!! Ter-
blanche,30 Calne,6 and in our own laboratory23 
was even more noteworthy. In some experiments 
with pigs not treated with immunosuppressive 
agents, identifiable homograft rejection did not 
occur. In other experiments, rejection was indolent 
and spontaneously reversed. These suprising 
results occurred in only a minority of animals. 
Nevertheless, they had to be attributed to some 
special privilege of the liver since porcine skin 12 
and kidney grafts6 were regularly rejected in the 
usual way. 
These observations in both dogs and pigs (and 
now in other animals) invited certain hypotheses 
in addition to the one stated above that the new 
liver helped create an internal milieu favorable to 
itself. Other possibilities23 were that the liver was 
inherently less antigenic than other organs, that 
its relatively great antigenic mass was a beneficial 
factor, that its enormous regenerative capacity 
made it less susceptible than other tissues to the 
effects of chronic rejection, or, in the view of Calne,3 
that it possessed or released some special factor 
promoting the induction of specific immunologic 
tolerance. 
Whatever the explanation, overstatement of the 
case for the liver's privileged status could lead to 
erroneous conclusions about the practical require-
ments for immunosuppressive therapy following 
hepatic transplantation in man. At a research 
level, another danger could stem from the notion 
that hepatic transplantation, especially in the pig, 
is somehow qualitatively unique. The fallacy of 
such a contention is obvious from the fact that 
even in the "easy" pig model, the majority of un-
treated liver recipients died from acute rejection.2:! 
In dogs and humans, control of hepatic rejection 
may be difficult or impossible in spite of very heavy 
immunosuppressive therapy.23.24 
Rejection Reversal 
Instead of being unique, it is probable that liver 
homografts vary from other organs only by degree 
in the host immunologic response they evoke in all 
species including the pig. In this context, two key 
observations initially made with kidneyS' I. 26 
have been extended to the livern 24 and there is 
little doubt that they apply to other tissues as 
well. The first is the reversibility of rejection. In 
patients, reversal usually requires intensification 
of treatment but it has sometimes been noted with-
out any change in the pre-existing therapy, sug-
gesting that such recoveries had an element of 
spontaneity. As mentioned earlier, "spontaneous 
remission" of rejection in the absence of all therapy 
has been seen both in dogs and in pigs, particularly 
the latter. The events with the liver in all three 
species are undoubtedly expressions of the same 
phenomenon, differing only quantitatively. 
Graft Acceptance 
The second observation of overriding practical 
and theoretical interest concerns what has already 
been referred to as "graft acceptance." In many of 
the human kidney recipients treated almost a 
decade ago,2!. 23. 26 it was shown that a melting 
away of host resistance to the homograft occurred 
surprisingly early after transplantation, often 
following an acute rejection crisis. This was mani-
fested by eventual declines in the doses of immuno-
suppressive agents necessary to retain stable graft 
function. In many patients, the level of chronic 
immunosuppression has proved to be less than 
that which at the outset failed to prevent the onset 
of a severe rejection. 
It is probable that all treatment could be stopped 
in some of these human renal recipients whom we 
have now followed for many years, but such a 
drastic final step has not been thought to be war-
ranted. However, as described earlier, therapy has 
been successfully discontinued in dogs after kidney 
transplantation and even more consistently after 
liver replacement, indicating that graft acceptance 
may become very complete. In pigs, the barrier of 
natural host resistance is apparently low enough 
that the cycle of hepatic graft acceptance can be 
completed without any immunosuppression at all. 
Viewed in this way, the curious pig liver experi-
ments become only a special example of, rather 
than an exception to, a general principle of trans-
plantation. Recently, Perper and his associates17 
have provided evidence to support both this con-
cept and the original idea that there is a slight but 
limited biologic advantage in transplanting the 
liver versus the kidney. Perper showed that a 3 
day course of heterologous antilymphocyte glob-
ulin (ALG) treatment or other short-term thera-
peutic maneuvers in pigs permitted long-term 
acceptance of kidneys in precisely the same way as 
occurs with the liver in the absence of all iatro-
genic intervention. 
Explanations for Graft Acceptance 
It is indisputable that some element of accept-
ance of various kinds of grafts occurs often in 
humans under the appropriate conditions of im-
munosuppression and that the degree to which this 
develops is a prime determinant of the long-term 
prognosis. Unfortunately, the reason for the 
change in the host-graft relationship is not known. 
More than one immunologic pathway may be 
involved. 
Immunologic Tolerance. Schwartz and Dame-
shek20 first suggested the possibility that the con-
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Figure 1 Hypothetical me-
chanisms by which nonspecific 
immunosuppression may lead to 
selective abrogation of the host 
immune response. Special sus-
ceptibility to these agents of a 
fraction of the lymphoid popula-
tion could lead to exhaustion of a 
clone, and hence, tolerance. 
Since maintenance of such cell 
lines even in adult life is appa-
rently thymic-dependent in ex-
perimental animals, thymec-
tomy would be expected to aid 
the process; this appears to be 
true in rodents, but such an ef-
fect of thymus removal has not 
been proved in dogs or humans 
(see discussion in text). A possi-
ble protective role of immuno-
globulins elaborated by the rep-
licating cells is also shown. 
.----'---, ,-L---, ~ ,--t---, ---'--
• • (9 ~(., ~ ~ (~(I) ~ 
--------, ...... ----------> --------,... 
I m m un e ~ - - - - - - - -> - - - - - - -> 
~----------> . -------> 
_S_u_p_p_r_e_s_si_o_n----' t:-= -= -= -= -= = ~ ~ =~-~I",.-, .. "",;,\- --t -=- = = ~~ 
Immunoglobulins 
tinuous presence of a transplanted organ in a host 
being treated with immunosuppressive therapy 
could lead to a selective loss of responsiveness to 
antigens. The suggestion is that specific lympho-
cyte clones, induced to replicate by the graft anti-
gens, are thereby rendered more vulnerable to the 
killing effect of immunosuppressive agents than 
the rest of the lymphocyte population (Fig. 1). 
Inasmuch as the maintenance of such activated 
cell lines appears to be thymus-dependent even in 
adult life, at least in some experimental animals, 
it is reasonable to be curious about the effect of 
thymectomy as an adjuvant immunosuppressive 
measure. The results of thymectomy in a series of 
our human renal transplants were inconclusive. 27 
While the patients with thymic excision did not 
have better survival or superior renal function, 
there were fewer and less severe histopathologic 
abnormalities when their grafts were examined 
long after transplantation. 
The concept of specific, differential tolerance 
through "clone stripping" can partly explain the 
characteristic cycle of rejection and reversal oc-
curring after whole-organ transplantation both in 
treated animals and man and in the weak and self-
resolving crises in the untreated pig. Moreover, it 
is consistent with the fact that a wide variety of 
agents that are capable of general immunologic 
crippling can also provide specificity of action 
under the stipulated conditions of immunosup-
pressive treatment during presence of the antigen. 
To date, few investigations have been per-
formed in human recipients of chronically func-
tioning renal homo grafts to establish the presence 
or absence of classic immunologic tolerance to 
their donor tissue. It would be interesting to know 
if skin from these donors would be accepted. One 
of the reasons why such a test has not been 
carried out in patients is the potential risk of 
precipitating an immune reaction that could 
damage the graft. 15 Of course, viable donor tissue 
is not available for such an experiment in liver 
recipients even if this were a desirable under-
taking. 
Amos and Baclt have provided evidence that at 
least some kidney recipients develop true toler-
ance to their donors. They performed mixed 
lymphocyte cultures with peripheral blood from a 
number of our renal recipients and their donors 2 
to 4 years after transplantation. In some cases, the 
recipient lymphocytes no longer developed blast 
transformation when exposed to killed donor white 
cells, although they reacted vigorously to third-
party cells. However, in other cases recipient 
lymphocytes retained their reactivity to donor 
cells. In experiments, dogs with tolerated kidneys 
may promptly reject skin or kidney grafts from the 
original donor. 
Enhancement. These ambivalent findings do not 
disprove tolerance through "clone stripping" so 
much as they suggest that at least another mech-
anism of graft acceptance may be involved. One 
such mechanism, termed "enhancement," has been 
envisioned as a process in which immunoglobu-
lins synthesized by the activated lymphoid tissues 
circulate to the target tissue and coat it or protect 
it in some way that is not yet understood (see Fig. 
1). Antigraft antibodies, selectively capable of 
being absorbed by the nucleated cells of the 
original donor, have been detected in patients 
carrying well tolerated renal transplants. Exten-
sive immunoglobulin deposition has been demon-
strated by immunofluorescence techniques in 
long-functioning kidney homografts,19 but this 
latter finding usually has an adverse connotation 
rather than a favorable one. 
An understanding of the means by which grafts 
are accepted may hold the key to improvements in 
therapy. When we come to know more about these 
mechanisms, it may prove possible to arrange the 
conditions required for graft acceptance in advance 
of the arrival of the homograft rather than to rely 
on their development secondary to the events of 
rejection. The result might well be the prevention 
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of rejection with far less immunosuppressive crip-
pling of the immune apparatus in the critical post-
operative period. In this connection it is heartening 
to refer to the experiments of Stuart and his 
colleagues at the University of Chicago.29 When 
enhancing antibodies were combined with toler-
ance induction by donor-specific antigen pretreat-
ment, rat renal transplants functioned 18 months 
and longer even in the presence of strong histo-
compatibility barriers, the absence of immuno-
suppression, and the retention of immunologic 
reactivity to most antigens. 
TISSUE TYPING 
Another way by which clinical results might be 
improved would be effective donor-recipient 
matching of histocompatibility (HL-A) antigens as 
discussed elsewhere in this chapter. Unfortunately, 
the state of our knowledge about human histocom-
patibility systems is still primitive. While a good 
match between siblings appears to provide a more 
favorable prognosis after renal transplantation 
than a poor match, our experience with unrelated 
subjects provides no such correlation27 and has led 
us for the moment to ignore the question ofHL-A 
matching altogether in cadaveric cases. In liver 
transplantation, in which nonrelated cadaveric 
sources must be utilized exclusively, we have had 
some excellent results with poor histocompati-
bility matches and some discouraging results 
despite close matches. 23 Not only has a correlation 
with tissue typing been absent with regard to 
clinical outcome, but no connection at all has been 
found between the quality of the match and the 
appearance of the hepatic homograft at subsequent 
histologic examination.23 Until the discrimination 
of the matching methods in nonrelated cases is 
improved, it is difficult to justify denying a patient 
an available organ solely on the basis of poor 
serologic histocompatibility. Nor do we even use 
most favorable matching as an instrument of 
selection among candidates for transplantation. 
At the present time, a more valid criterion may be 
who has the most pressing need. 
THE PROCUREMENT OF ORGANS 
In contrast to typing, the procurement of a fresh, 
functioning, nonischemic liver is of paramount 
advantage and provides the strongest correlation 
with success or failure. 
The Source of Donors 
In discussing homograft quality, the technical 
details of organ preservation become interwoven 
with, or even distinctly secondary to, ethical con-
siderations about the conditions for the pronounce-
ment of donor death and problems of cooperation 
by the medical and lay community. Unquestion-
ably, one of the most important advances that have 
been made in transplantation has been social in 
nature, consisting of acceptance by the public of 
the concept of cadaveric organ removal. In turn, 
this was made possible by a willingness of many 
members of the medical profession to identify 
potential donors, to approach family members at 
a time of their bereavement, or to indicate in other 
ways their belief in the propriety of these efforts. 
By avoiding the glare of lay publicity, this can be 
and has been done impersonally and with restraint 
in many areas without exaggeration and without 
infringing on the personal right to privacy of the 
individuals involved. 
Pronouncement of Death 
After the donor has been identified and made 
available, an effort is made to maintain good liver 
perfusion up to the last possible moment in order 
to minimize the ischemic damage that even a short 
unperfused period may wreak under normother-
mic conditions. The extraordinary resuscitative 
efforts required in the donor to prevent circulatory 
depression in the face of a hopeless prognosis usu-
ally require explanation to relatives. 
Ultimately, a final decision to discontinue sup-
portive measures may be made after all is in readi-
ness to proceed with the recipient. During the first 
years of liver transplantation at the University of 
Colorado, a considerable physiologic penalty was 
accepted because of criteria that required both 
brain death and cessation of heartbeat before 
commencing with organ removal. The price of this 
insistence was the loss of critical time, and vari-
able ischemic damage both during the agonal 
stages of circulatory failure and in the minutes 
after cardiac arrest.2:1 
The reason for accepting these conditions was 
the fear that the quality of terminal care for the 
donor might be compromised by the pronounce-
ment of death in the presence of a heartbeat. In 
1968 our criteria were liberalized in accordance 
with the concept of irreversible brain injury as it 
was first outlined and applied at the University 
of Louvain, Belgium, by Alexandre,! and later 
defended by the Harvard ad hoc committee.8 Ex-
perience since then has convinced us that anxieties 
about terminal care were unfounded. Acceptance 
of the brain death concept alleviated one of the 
most serious problems in liver transplantation, 
for it virtually eliminated the interval of normo-
thermic ischemic injury and often permitted the 
organ to be taken in the presence of an intact and 
effective circulation. 
Preservation Techniques 
The subsequent preservation of the liver is also 
of vital importance and has been accomplished by 
one or more preservation modalities, depending on 
circumstances, and always including organ hypo-
thermia.23 With the advantages conferred by the 
acceptance of brain death, it is often possible to 
maintain a naturally perfused liver in situ prac-
tically up to the moment of its excision. After re-
moval, quick cooling may be accomplished by run-
ning a chilled electrolyte solution through the 
portal vein, thus lowering the donor organ tem-
perature to about 10 or 15° C., which is sufficient 
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for adequate preservation during the hour or so 
required for the vascular anastomoses in the 
recipient. In the event of a heart standstill before 
the recipient is ready, it is possible to employ the 
procedure used before 1968, when cardiac arrest 
was required before proceeding; by means of a 
heart-lung machine, circulation in the cadaver is 
reinstituted in combination with cooling (Fig. 2). 
When longer periods of preservation and storage 
are needed (which has not been the case at our 
center since 1968) the liver may be removed and 
placed in a chamber such as that devised by Brett-
schneider,' which combines perfusion, refrigera-
tion, and hyperbaric oxygenation. In one of our 
cases, the perfusion chamber permitted preserva-
tion of a liver without undue damage for a period 
of 9 hours, long enough for the recipient to make a 
transcontinental flight to Denver and to be pre-
pared for surgery. 
SURGICAL TECHNIQUES OF 
ORTHOTOPIC TRANSPLANTATION 
Species Differences 
The procedure of liver replacement was first 
accomplished in dogs. The transition from animal 
experimentation to clinical application required 
some major technical adjustments and in at least 
one important and unexpected way demonstrated 
the need to be alert to the special requirements of 
human physiology. With removal of the host liver 
it is necessary to cross-clamp temporarily the great 
veins draining the intestines (portal vein) and the 
lower half of the body (inferior vena cava). If pro-
vision is not made for decompression of the distal 
venous pools during the anhepatic phase, dogs 
.~ 
\ 
dOyto. Figure 2 Technique of extra-
corporeal perfusion with a heart-
lung machine. Catheters are in-
serted via the femoral vessels into 
the aorta and vena cava as soon as 
possible after death. The extra-
corporeal circuit is primed with a 
glucose or electrolyte solution to 
which procaine and heparin are 
added. The cadaver is thus anti-
coagulated with the first surge of 
the pump. Temperature control is 
provided by the heat exchanger. 
Cross-clamping the thoracic aorta 
limits perfusion to the lower part 
of the body. 
either die of shock on the operating table or expire 
at a later time because of irreparable damage to 
the mesenteric capillary bed. It was assumed that 
the same precaution would be necessary in hu-
mans and this was accomplished in the first five 
human recipients by plastic bypasses from the 
splenic or femoral vein or both to the external 
jugular veins. There was a dismaying incidence of 
pulmonary emboli, which caused or contributed to 
the death of three of the first five recipients. It 
was suspected either that the clots originated 
within the bypasses and were actually carried to 
the lungs during the operation or that they formed 
a short time later at or near the site where the 
femoral catheter had been inserted. 
The omission of the venous decompression proce-
dure in later patients did not produce any serious 
or long-lasting circulatory effects, including hypo-
tension. Although a slight duskiness of the in-
testine developed in some recipients, it immedi-
ately disappeared when blood flow was restored 
through the reconstructed venous channels. One 
can explain the ease with which portal and vena 
caval cross-clamping was tolerated by man's in-
herently richer network of potential collateral 
channels for the return of blood to the right heart, 
and by the presumed additional increase in their 
size and ramifications in consequence of the under-
lying liver disease.":l Venous decompression with 
bypasses has not been used in any recent case. 
Omission of this step has been a major technical 
advance. 
Vascular Anomalies 
In planning a liver transplantation, the surgeon 
must be prepared for a high incidence of anatomic 
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Figure 3 Recipient opera-
tions. In most recent cases chole-
cystoduodenostomy has been 
performed for biliary drainage 
as shown. C.a. = celiac axis; C.d. 
= common duct; G.B. = gall-
bladder; H.a. = hepatic artery; 
I.V.C. = inferior vena cava; P.V. 
= portal vein; S.m.a. = superior 
mesenteric artery. A, The kind 
of arterial anastomosis most 
commonly used. The homograft 
celiac axis or common hepatic 
artery is attached to the proper 
or common hepatic artery of the 
recipient. B, Arterial recon-
struction of two homograft 
arteries. The vessels are indi-
vidualy anastomosed to the 
branches of the recipient proper 
hepatic artery. C, Anastomosis 
of the homograft aorta to the 
recipient aorta. The variation 
was used in a 16 month old re-
cipient because of the double 
arterial supply to the trans-
planted liver. 
variations in either the graft or host structures.23 
These have been encountered in almost 40 per cent 
of our cases. Multiple arteries have been the most 
frequent anomalies (Fig. 3). When these have been 
in the recipient, most commonly the graft celiac 
axis has been connected to the host aorta. When 
the multiplicity has been of the transplant vessels, 
multiple arterial anastomoses or other variant 
procedures have been used. There is no question 
that the need to improvise in these situations im-
poses an extra risk, particularly in very young 
recipients whose arteries are quite small and thin-
walled even under the best of technical circum-
stances. In patients with biliary atresia, anomal-
ies may be encountered of which the complexity 
may be so great as to make it virtually impossible 
to succeed. Two of our infants with biliary atresia 
had a curious type of malrotation in which the 
portal vein passed in front of the pancreas and 
duodenum, the arterial blood supply issuing from 
the superior mesenteric artery rather than from 
the celiac axis, which was absent. 2:l In addition, 
the retrohepatic inferior vena cava was missing. 
In both cases, corrective maneuvers to overcome 
the structural deficits were unsuccessful and the 
patients died within a few days. 
Bile Duct Problems 
The problems of obtaining adequate bile drain-
age and avoiding technical errors that may lead to 
leakage or obstruction may also be complicated by 
the presence of biliary tract anomalies, and the 
surgeon must be prepared to tailor his proce-
dure to the individual case. 
Choice of Biliary Drainage. An end-to-end 
llepatic a. 
(jascl'o·dUQ a 
anastomosis of the common duct, if it were normal, 
would have the advantage of preserving the 
sphincter of Oddi, thus providing drainage 
through a normal distal channel and reducing the 
chances of reflux of food or bacteria. This method, 
which of course is not available in the case ofbili-
ary atresia, is considered the procedure of choice 
by some surgeons. Our own experience has led us 
to believe that this anastomosis involves too high a 
risk ofleakage and infection. Moreover, it has been 
considered undesirable to leave a T tube prosthe-
sis or a drain in an immunosuppressed patient 
after duct reconstruction in close proximity to the 
portal venous and hepatic arterial anastomoses. 
Finally, there may not always be an adequate 
blood supply to the distal portion of the homograft 
common duct, which normally receives its prin-
cipal arterialization from retroduodenal sources 
but which now must depend on retrograde flow 
from arteries in the central hepatic hilum. There-
fore, when feasible, the safer if somewhat less 
elegant technique is used - anastomosing the gall-
bladder directly to the duodenum and ligating the 
common duct (see Fig. 3). 
Bile Duct Anomolies. Ligation of the transplant 
common duct in conjunction with cholecystoduo-
denostomy may be dangerous if anomalies are not 
recognized. Communication between the cystic 
and common ducts may not always be at the point 
of their juncture (Fig. 4). In one patient the ducts 
were externally fused but separated by an inter-
nal septum; in another the homograft cystic duct 
passed behind the common duct and descended for 
almost 2 inches as one compartment of a double-
barreled lumen. In both cases, biliary drainage 
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Homograft liver 
duodenostomy 
Right B left 
hepatic duct 
Figure 4 The anatomic basis for a technical error 
which cost the life of a patient. Distal ligation of the 
double-barreled extrahepatic duct system resulted in 
total biliary obstruction. 
was inadvertently obstructed when the common 
duct ligature closed both parallel passages, a 
technical error that subsequent surgery failed to 
correct and that proved fatal. 
Some of the vascular and ductal anomalies could 
have been diagnosed preoperatively, resulting 
either in better planning for surgery or a decision 
not to operate at all. These earlier cases did not, 
however, have the benefits ofthe extensive arteri-
ography and cholangiography that are now used 
routinely in the donor and sometimes in the 
recipient as well. 
Hemorrhage 
Other problems during and after operation may 
be caused by derangements in the coagulation 
mechanism that may result in either hemorrhage 
or thrombosis.23 As one would expect, acute bleed-
ing can be particularly troublesome during the 
actual liver transplantation. The very nature of 
the underlying hepatic pathologic process produces 
portal hypertension in nearly every patient and 
the nature of the operation tends to exaggerate it. 
The usual consequence is mechanical bleeding 
that can rapidly assume nightmare proportions 
during the procedure. Many of the normal coagula-
tion factors that might help control hemorrhage 
are dependent on the liver and are therefore defec-
tive in the diseased recipient. These coagulation 
factors may be even more deficient during the 
anhepatic phase, or subsequently they may be of 
dubious quality, depending on the state of preser-
vation of the homograft, on how much ischemia it 
has suffered, and on how much immediate func-
tional capability it has retained. 
When hemorrhage occurs, the surgeon's chal-
lenge is to use any and all available hemostatic 
tactics-ligating, suturing, cauterizing- until the 
revascularized homograft can participate in what 
is hoped will be appropriate coagulation function. 
With our earlier patients, whose homografts were 
generally of less than optimal quality for the 
reasons stated earlier, an attempt was made to 
treat bleeding problems by administering thrombo-
genic agents. However, hypercoagulability was 
caused in some instances. The unacceptable inci-
dence of pulmonary embolism in these patients led 
us to abandon this approach. 
In retrospect, it is possible that the coagulability 
induced by exogenous thrombogenic agents might 
be prohibitively additive to the clotting brought 
about by the homograft which, when it begins to 
function, may overreact. Indeed, the better the 
condition of the transplant, the greater the risk of 
unwanted coagulation. Almost every series of liver 
transplants, including our own, has at least one 
example of thrombosis of the hepatic arterial cir-
culation to which a rebound phenomenon may 
have contributed. The use of anticoagulants to 
forestall this emergency is dangerous. Docu-
mented intravascular clotting during the opera-
tion would be an indication for heparin, but such 
proof is hard to obtain. Moreover, heparinization 
is a double-edged maneuver; depressed clotting can 
have devastating effects on patients submitted to 
such major trauma and with so many potential 
bleeding sites. 
In general, it is now considered best to avoid 
iatrogenic manipulation of the clotting process 
with either thrombogenic or anticoagulant agents. 
Instead, our current approach is to leave correc-
tion of coagulation abnormalities to natural 
processes, intervening only under special circum-
stances and for very specific indications. 
Anesthesia 
During operation, there are other metabolic ab-
normalities than those concerned with coagulation. 
These contribute to the complexity of anesthetic 
management. Not only is the procedure long and 
difficult, but even more important, it is an opera-
tion on the primary organ involved in the metabol-
ism and detoxification of most common anesthetics. 
At any point during the operation, the liver is 
either inherently impaired, absent, or untried in 
its new setting. Hence, the task of the anesthesi-
ologist is to administer correctly drugs that, first, 
are not hepatotoxic and, second, do" not depend 
primarily on the liver for their degradation. In 
our cases, reliance has been placed mainly on 
combinations of volatile agents such as fluoroxene 
and nitrous oxide-oxygen in nonexplosive concen-
trations. Such management permits use of the 
electrocautery, gives flexibility in lightening or 
deepening anesthesia, and allows anesthesia to 
be abruptly stopped if required by changing physi-
6logic circumstances."" 
Other Operative Problems 
The foregoing are some selected difficulties asso-
ciated with liver transplantation. There is a long 
list of other technical pitfalls: adrenal venous in-
farction, air embolism, and crushing of the right 
phrenic nerve by too high a clamp on the upper 
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vena caval cuff, to mention but a few. The reader 
interested in a more detailed discussion of these 
and other surgical problems is referred to a 
recently published text.23 These technical matters 
have played a major role in the mortality encoun-
tered in our first cases. However, deaths from such 
causes are avoidable. Consequently, surgical 
technique is of less critical significance to the 
future of transplantation than the immunologic 
problems. The most important factor in successful 
transplantation remains the prevention of graft 
rejection by the host. 
IMMUNOSUPPRESSION 
The immunosuppressive therapy in liver trans-
plantation has borrowed heavily from the experi-
ence gained with human renal transplants. Two 
general treatment programs were evolved with the 
simpler kidney model and then applied to the 
liver recipients. 
Double Drug Therapy 
The first protocol, which was used from 1962 to 
1966 for all organ recipients at the University of 
Colorado, consisted of "double drug" treatment 
with azathioprine and the synthetic adrenal corti-
cal steroid, prednisone.21 Evolution of the use of 
these two agents together, appreciation of their 
marked synergism, and demonstration that rejec-
tion could be readily reversed by increasing the 
steroid doses were among the advances that made 
clinical transplantation practical and that intro-
duced what is known as the modern era of this 
field. But in spite of fair results with renal trans-
plantation, the double drug therapy either did not 
prevent rejection of hepatic homo grafts or else it 
proved too toxic to permit host survival. Six pa-
tients treated with liver transplantation from 1963 
to 1965 died in a month or less. 
Triple Drug Therapy Including ALG 
In 1966, heterologous antilymphocyte serum 
(ALG) was introduced clinically at our center as a 
third immunosuppressive agent, added to the 
drugs mentioned above.23,28 Since then, this triple 
drug therapy has been given to all our renal, 
hepatic, and cardiac recipients. In our experience, 
rejection has been more easily and regularly con-
trolled, and the risks and morbidity imposed by the 
necessity for high-dose steroid therapy have been 
reduced. 
Not all transplant surgeons concede the need for 
ALG. However, those most familiar with its use 
have enthusiastically confirmed the value of the 
tri pIe drug regimen, including Traeger of France, 32 
and Pichlmayr of Germany,t8 and most recently 
Najarian and Simmons of Minneapolis. 1H These 
last authors advocate producing the heterologous 
serum with cultured lymphoblasts as the antigen 
rather than mature lymphoid tissue and recom-
mend administering the subsequently refined ALG 
by the intravenous rather than the originally 
employed intramuscular route. 
All of our human liver recipients who achieved 
chronic survival were treated with the combina-
tion of azathioprine, prednisone, and intramus-
cular ALG. In the event of a rejection episode, it is 
the steroid component that has proved to be the 
agent most amenable to quick adjustment of dos-
age according to need. 
Penalties of Immunosuppression 
Some of the hypotheses of the actions of these 
immunosuppressive drugs have been discussed 
elsewhere23 and reviewed earlier in thi& chapter. 
Suffice it to say, as was emphasized at the outset of 
this chapter, the method by which these agents are 
used in conjunction with the actual transplanta-
tion may conspire to permit selective abrogation of 
the host rejection response. If this were not true, 
there would be little hope of rehabilitating pa-
tients and returning them to life in an unrestricted 
environment since each of the individual agents 
Figure 5 An explanation of the predisposition of the 
liver to bacterial sepsis. Presumably the invading micro-
organisms enter via the portal vein or through the re-
constructed biliary tract. (From Starzl, T. E., et al.: Ann. 
Surg., 168:392,1968.) 
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can cause general immunologic crippling more or 
less in proportion to the dose used. 
Risks with All Organs. The most obvious penalty 
of a depressed immune system is heightened sus-
ceptibility to infection?1, 2:l However, it has also 
become obvious that chronically immunosup-
pressed patients have an increased vulnerability 
to de novo malignancies.n ,27 In our own series of 
chronic survivors after renal transplantation, 
more than 5 per cent have developed either mesen-
chymal or epithelial malignant tumors. Almost 
all other major transplantation centers have 
recorded this complication, which is presumably 
due to failure of the depressed immunologic 
surveillance mechanism to identify the tumor 
tissues as alien and to eliminate them or restrict 
their growth. 
Extra Risks for Liver Recipients. In addition to the 
foregoing general liabilities of immunosuppres-
sion, there are some special risks for the liver 
candidate. One is the fact that hepatic injury in 
all kinds of organ recipients has commonly been 
produced by the agents, individually or in com-
bination, of the therapeutic regimen.23 In some in-
stances, virus hepatitis, apparently made chronic 
by the partial immunologic invalidism of the host, 
has been a plausible explanation. In others, 
hepatotoxicity of the drugs was probably responsi-
ble. With liver malfunction, dose control of some of 
the agents may become difficult since the liver par-
ticipates in their pathways of action or degrada-
tion. These hepatic factors are obviously important 
in any situation requiring immunosuppression, 
but they have heightened significance for a trau-
Figure 6 Postoperative technetium scans of the liver in a 13 month old infant whose indication for orthotopic 
transplantation was biliary atresia. 2 days: The small homograft is normal. 10 days: An increase in size is evident 
although the general configuration of the organ is still normal. 20 days: No further change is noted. 25 days: The 
examination was conducted as an emergency when gram-negative septicemia developed and very high increases in 
the transaminases appeared. Areas of decreased isotope uptake are obvious in the right lobe and the central part 
of the liver. 27 days: A striking extension of the process can be seen less than 48 hours later. A debridement procedure 
was carried out the same evening. 31 days: Four days after debridement the radiographic appearance was improved. 
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matized liver transplanted to a new and hostile 
environment. 
It was mentioned in the preceding section that 
infection was a major risk to any immunosup-
pressed patient. In the liver recipient, postopera-
tive sepsis of the graft itself has proved to be a 
special problem, without doubt partly because of 
the anatomic location of the orthotopically placed 
organ, interposed between the intestinal tract and 
the heart. Bacteria from the bowel, particularly of 
the gram-negative variety, can be brought into 
contact with the transplanted liver via the in-
testinal . veins draining into the portal vein or, 
alternatIvely, by retrograde spread up the duct 
system after passage through the biliary anas-
tomosis. (Fig. 5). In either event, the presence of 
nonviable hepatic tissue provides a perfect me-
dium for bacterial growth. Eventually, partial 
gangrene of the transplant can result, with charac-
teristic nonvisualizing areas on the liver scans 
(Fig. 6), gram-negative bacteremia, and all the 
findings of generalized sepsis. 
Avoidance of Homograft Sepsis. Early in our 
clinical series, the above findings of graft and sys-
temic infection led us to consider the essential 
problem to be one of bacterial invasion and thus 
prompted reductions of immunosuppression. Such 
decisions were tragically incorrect and were fol-
lowed by necrosis and infection of large parenchy-
mal areas. Experience soon taught that ischemia of 
portions of the liver was the initiating event, and 
that the basis for the ischemia was rejection.23 
Consequently, immunosuppression should ordi-
narily be increased rather than reduced if this 
complication is thought to be impending. When 
this was done by giving substantially higher doses 
of prednisone (as noted, the only highly dose-
~aneuverable component of the immunosuppres-
SIve triad), the incidence of regional hepatic 
gangrene fell to zero. It should be added that our 
prophylactic treatment protocol includes heavy 
antibiotic treatment for the first postoperative 
week, including agents effective against gram-
negative bacteria, after which this therapy is 
stopped. 
INDICATIONS FOR 
LIVER REPLACEMENT 
The understanding of regional hepatic gan-
grene that evolved illustrates well the learning 
process of caring for patients receiving a new kind 
of treatment. With the acquisition of experience, 
other important issues have also been clarified, 
including that of the indications for liver replace-
ment. A brief summary of our first 33 consecutive 
recipients, treated from March, 1963, to January, 
1970, can be used to illustrate these indications in 
the light of the results after a minimal potential 
follow-up of 14 months (Table 1). The 33 patients 
were aged 11 months to 68 years. 
Hepatic Malignancy 
The indication for 12 of these transplants was 
hepatoma or cholangiocarcinoma, and an addi-
tional unsuspected hepatoma was found in a 4 
year old child treated for extrahepatic biliary 
atresia. The latter is the only one of this group 
still alive, now 14 months after the operation· she 
has no evidence of recurrence of neoplasia. A~ for 
the other hepatoma patients, seven died within 39 
days, badly damaged homografts being a major 
cause of failure in five who were among our early 
patients in the period before the criterion of brain 
death was applied. Technical accidents with sub-
phrenic abscesses and bile peritonitis were the 
major causes of early death of the other two 
patients. 
Of the five hepatoma patients who had more pro-
longed survival (76, 143, 339, 400, and 432 days), 
metastases developed in all, and in four instances 
the recurrences were directly responsible for death. 
Because of this high rate of recurrent carcinoma, it 
has become our policy to consider liver replace-
ment for hepatoma only under the most exceptional 
circumstances even though our experience and 
that of Daloze of Montreal and CaIne of Cambridge 
have demonstrated the possibility of an occasional 
tumor cure. 
Biliary Atresia 
Far more desirable candidates are those without 
neoplasms, in spite of the fact that the technical 
difficulties in benign hepatic disease are more 
severe because the patients tend to be sicker and to 
have more advanced portal hypertension. More-
over, if the diagnosis is biliary atresia, an in-
creased incidence of vascular anomalies can be 
expected to compound the difficulties, together 
with the small size of the structures to be anas-
tomosed in these young patients.23 Nevertheless, 
the longest survivors of liver transplantation in 
the world are those who had this disorder (Fig. 7). 
Of o?r own series of 15 patients with biliary 
atresIa, treated 14 months or longer ago, including 
the child with the incidental hepatoma already 
mentioned, five lived for lopger than 1 year and 
two are still surviving with completely normal 
l~ver function, P/s years and 23/4 years, respec-
tIvely, after operation. The three late deaths after 
13, 13112, and 30 months were from recurrent 
hepatic insufficiency caused in two instances by 
chronic rejection, but probably in the third by 
indolent virus hepatitis. Another four children 
survived 61 to 186 days, all expiring from regional 
hepatic gangrene for which the apparent cause 
was too little immunosuppression in the early 
post-transplantation period. The six other recipi-
ents with biliary atresia died within the first 40 
days, two from hepatic necrosis probably attrib-
utable to ischemia of the donor organ, two from 
thrombosis of the hepatic artery, and the remain-
ing patient from generalized infection and 
pneumonia. 
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Figure 7 The course of a 4 year old child after orthotopic liver transplantation for the indication of biliary atresia. 
Note the rejection episodes at 1 month and 21/2 months, which were easily controlled. The patient continues to be 
in satisfactory health now, 23/4 years after operation. 
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Figure 8 Course of a child with Wilson's disease and hepatic cirrhosis who was treated with liver replacement in 
July, 1969. He remains well and has no stigmata of recurrent Wilson's disease. (From DuBois, R. S., et al.: Lancet, 
1 :505, 1971.) 
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Cirrhosis 
Six patients were treated for cirrhosis a year or 
longer ago, with the disappointing record of five 
early deaths. Reasons for the heavy acute mortal-
ity included the extremely poor physical condition 
of the recipients, major hemorrhage due to portal 
hypertension and depressed coagulation, and tech-
nical or metabolic mishaps. The survivor is an 11 
year old child whose cirrhosis was secondary to 
Wilson's disease. After liver replacement, the child 
suffered an extremely severe rejection crisis, but 
the process was eventually reversed, with normal 
liver function continuing now more than a year 
and a half after the operation (Fig. 8). Moreover, 
the new liver, which was biopsied at 6 and 17 
months, has not reaccumulated copper and it ap-
pears to have corrected the genetic error in copper 
metabolism, a finding that may be important in 
the search for the etiology of this disease." 
Undoubtedly, one reason for the bad experience 
with cirrhotic patients has been a reluctance to 
recommend such therapy except in the agonal 
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stages of the disease. Now that the feasibility of 
long-term survival and rehabilitation has been 
demonstrated, transplantation at an earlier time 
probably should be considered, particularly in 
cases of postnecrotic cirrhosis in which the maxi-
mal value of medical management and of abstin-
ence from alcohol has already been realized. 
Hepatitis 
In addition to the 33 consecutive liver reCIpI-
ents recorded above, another patient with a shorter 
follow-up will now be mentioned because of the 
exceptionally interesting circumstances of trans-
plantation.:ll This is a 28 year old woman with 
chronic active hepatitis who was operated on in 
August, 1970. For a year before the operation, as 
well as on the day of the transplantation, immuno-
diffusion tests for the hepatitis-associated (Aus-
tralia) antigen3 were positive. She provided an 
opportunity to examine the thesis that this anti-
gen has an essentially hepatic source. The argu-
ment for this proposition was supported by the 
- + +++ + + + + 
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Figure 9 The course of a patient who was terminally ill with chronic aggressive hepatitis, Australia IAu) antigen-
positive. She was treated by liver replacement. Note that all serologic evidence of serum hepatitis disappeared 
immediately after operation only to return some weeks later. AG, agarose gel micro-Ouchterlony test for Au antigen. 
IEOP, quantitative immunoelectro-osmophoresis test for Au antigen. CF, complement fixation test for Au antigen. 
ACA, anticomplementary activity, which is thought to reflect the presence of circulating antigen-antibody complexes; 
the test is not immunologically specific for Au antigen. Normal Bessey-Lowry (B-L) units for alkaline phosphatase 
are less than 3. (From Torisu, M., et al.: Ann. Surg., 174:620,1971.) 
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immediate disappearance of the Australia antigen 
from the bloodstream after the operation (Fig. 9). 
About 6 weeks later, it reappeared and within a 
few days there followed an attack of acute serum 
hepatitis with joint pain, anorexia, jaundice, and 
evidence of hepatic necrosis by transaminase 
determinations. Fortunately, her liver function 
abnormalities have regressed nearly completely 
(Fig. 9), but she remains Australia antigen-
positive, now 8 months post-transplantation. It 
remains to be seen if the virus will condemn the 
new liver to the same fate as the old one, if the 
long-term pace of the infection will be affected by 
the chronic immunosuppression, and if the pa-
tient will continue to be a virus carrier. 
The case has other interesting implications. It is 
customary to think of the incubation period of in-
fectious diseases in terms of the host immune de-
fenses. In this patient, the immune apparatus was 
retained but systematically weakened. Yet the 
latent period of the disease was about that to be 
expected with a fresh infection, indicating that the 
incubation period in this patient was primarily 
concerned with the target organ.31 
AUXILIARY LIVER TRANSPLANTATION 
Both in experimental animals and in patients, 
survival after auxiliary transplantation has been 
inferior to that with the orthotopic procedure. The 
reasons for these disappointing results have not 
been entirely clear, but plausible explanations 
have been advanced indicting both metabolic and 
mechanical factors. 
Metabolic Considerations 
When auxiliary liver transplantation was first 
attempted in immunosuppressed canine recipi-
ents, a curious and disquieting observation was 
soon made.25 The extra organs underwent rapid 
shrinkage which was usually evident within 2 
weeks and which was very advanced at all times 
after 1 month. Many subsequent studies, espe-
cially those of Marchioro,13, 14 have been designed 
to explain the atrophy and to define the conditions 
for its avoidance. 
The results of these investigations, which have 
been reviewed in detail elsewhere,23 have shown 
that two coexisting livers may engage in a physi-
ologic competition that can result in serious injury 
to one or the other organ. The competitive poten-
tial of the individual livers can be unbalanced by a 
variety of factors. Advantageous conditions in-
clude perfusion of adequate quantities of blood, 
particularly if the portal component is derived 
from the intestinal venous (splanchnic) efHuent. 
Handicaps may be imposed by obstructing the 
biliary drainage, by reducing the total blood flow, 
by depriving the organ of flow from splanchnic 
sources, or by hindering it in a variety of other 
ways. The favored liver in such a situation will 
flourish while the disadvantaged one shrinks. 
The first step in minimizing or preventing 
auxiliary homograft atrophy in animal experi-
ments is to avoid situations in which the trans-
planted liver is placed at a physiologic disad-
vantage. The second step is to fully appreciate 
that the homograft requires a better than equal 
environmental opportunity to counteract the 
immunologic duress which it alone must suffer, if 
there is not a perfect histocompatibility match or 
else totally effective immunosuppression. In dogs, 
auxiliary homograft atrophy can largely be pre-
vented if it is rearterialized and also given a portal 
inflow from the splanchnic venous system, and if 
the host liver is damaged with an Eck fistula. 
Additional privileges can be extended to the 
homograft by injuring the host liver in other ways, 
such as by ligation of the common duct. 
Clinical Experience 
It is virtually certain that the principle of inter-
liver competition applies in a general way to 
auxiliary hepatic transplantation in humans. 
However, what is not known is how important this 
factor will be. In adult patients with cirrhosis who 
might be candidates for hepatic transplantation, 
the competitive capacity of their own livers would 
be expected to be largely lost. On the other hand, 
it is conceivable that the host liver in pediatric 
victims of biliary atresia could be capable of 
promptly and seriously compromising the welfare 
of the new organ, since the hepatic parenchymal 
function in such patients is often surprisingly well 
maintained until just before death. 
These comments remain speculative since the 
longest survival to date after auxiliary liver trans-
plantation in man for the indication of hepatic 
failure has only been 34 days. In this case, the 
diagnosis was alcoholic cirrhosis. One day before 
transplantation a portacaval anastomosis was 
performed. The extra liver was obtained from a 12 
year old boy and placed in the right paravertebral 
gutter (Fig. 10). It functioned promptly for sev-
eral days until the onset of a rejection that was 
never reversed (Fig. 11). The patient eventually 
died of multiple infections. 
During life several liver scans were obtained 
with rose bengal iodine-131 and with gold-198 
isotopes. The rose bengal scans showed an approxi-
mately equal division of the specific radioactivity 
between the two livers. The gold isotope was con-
centrated almost exclusively in the homograft. 
With both kinds of studies there appeared to be a 
diminution in the size of the transplanted organ. 
The impression of atrophy could not be supported 
with certainty from the histopathologic studies of 
the homograft.23 Both hepatocyte loss and collapse 
of the supporting reticulin were features of the 
autopsy specimen, but these findings have been 
seen in orthotopic homografts. 
Recently, FortnerlO reported survivalof8 months 
after auxiliary liver transplantation for the indi-
cation of cholangiocarcinoma. The recipient was 
not dying of hepatic failure but had jaundice and 
intractable itching as the primary complaints. The 
auxiliary liver relieved these symptoms for sev-
eral weeks or months before the hyperbilirubine-
mia returned. Eventually, the cause of death was 
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B. 
Figure 10 The method of auxiliary liver transplantation used in a 47 year old patient; both donor and recipient 
had 0 blood type. The donor, a 12 year old boy, died from head trauma a few minutes after arrival at the hospital. 
Circulation was maintained for 45 minutes by external cardiac massage until the liver could be cooled by intraportal 
infusion of a chilled electrolyte solution. The subsequent hypothermic period required to remove the liver and revas-
cularize it in the recipient was 120 minutes. The outflow of the new organ was directed into the transected inferior 
vena cava. The portal blood supply was obtained from the common iliac vein. The hypogastric artery easily reached 
the celiac axis for end-to-end anastomosis. The liver was small enough to readily fit behind the reflected cecum. The 
operation was done in 5 hours with a blood loss of 2500 ml. A, Recipient operative field. B, Completed operation. 
Note the Roux-en-Y cholecystojejunostomy. (From Halgrimson, C. G., et al.: Arch. Surg., 93:107,1966.) 
suppurative cholangitis .of the native liver. The 
extent, if any, to which life was prolonged by inser-
tion of the homograft must be speculative. 
Many other attempts have been made at auxil-
iary hepatic homotransplantation of which only a 
few have been formally reported. Groth of Stock-
holm recently made an international survey and 
Figure 11 The course of the patient whose operation 
is depicted in Figure 10. There was apparently good ini-
tial function which later deteriorated when rejection was 
not controlled. Note the rapid development of azotemia 
late in the course. The gastrointestinal bleeding which 
was the immediate cause of death was due to widespread 
intestinal moniliasis; the exploratory laparotomy was 
made in an effort to control the bleeding. The immuno-
suppression in this case was the azathioprine and pred-
nisone. Profound leukopenia developed during the 
fourth postoperative week. 
found 34 cases. Among the 34 reported and unre-
ported recipients, there were only five, including 
the two patients just described, who lived for as 
long as 3 weeks. Within the total group there was 
an extraordinary incidence of technical difficulties. 
Moreover, almost all the patients who lived for 
more than a few days after operation developed 
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lethal pulmonary complications; abdominal over-
crowding by the extra organs appeared to have 
been a contributory factor in several instances. 
In view of this experience, it would seem pru-
dent to give special thought to the relative size of 
the homograft that is available. Our present belief 
is that the organ would ideally come from a 
smaller donor and would be placed in a recipient 
whose abdomen had been prepared by stretching 
with long-standing ascites. Such a perfect ana-
tomic situation was present in the recipient who 
li ved for 34 days. 
In the human it may be exceptionally difficult to 
provide an auxiliary liver with a portal flow from 
splanchnic venous sources. For this reason it is 
our present opinion that the best and simplest 
operations are compromise procedures such as that 
depicted in Figure 10. With such a technique, the 
homograft is revascularized in the right side of 
the abdomen as with portacaval transposition. 
Portal blood flow is diverted away from the host 
liver with a portacaval anastomosis. If the portal 
decompression can be done in advance ofthe trans-
plantation, insertion of the homograft is made 
immeasurably easier by obviating the need to 
work in a retroperitoneal space filled with high-
pressure venous collaterals. 
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VI 
Lung Transplantation 
Keith Reemtsma, M.D., and James P. Byrne, M.D. 
HISTORICAL ASPECTS 
Among the various organs, the lung was one of 
the last to be used in experimental transplantation. 
DemikhovH first investigated experimental pulmo-
nary transplantation extensively. He developed 
techniques for transplantation of lobes and the 
intact lung in dogs. Metras22 was the first to 
utilize the atrial cuff technique for the venous 
anastomosis. Juvenelle in 1951 performed the first 
successful orthotopic autograft, and function of 
this lung was demonstrable 35 months laterP In 
1963 Hardy reported the first human pulmonary 
allogTaft.20 
EXPERIMENTAL PULMONARY 
TRANSPLANTATION 
A reported mortality rate of 35 to 80 per cent 
attests to the complexity of experimental lung 
transplantation. '2 As these figures refer to autog-
enous reimplantation in dogs, which consistently 
survive pneumonectomy only, the anatomic and 
physiologic alterations produced by the reim-
planted lungs are appreciated. The autogenous re-
implanted canine lung has been the most fre-
quently employed preparation for evaluation of 
pulmonary function and technical factors. Results 
of these studies will be summarized in discussions 
of technical aspects and functional evaluation. 
Canine allografts and experiments in other ani-
mals will be discussed and compared separately. 
Technical Aspects of 
Autogenous Reimplantation 
The high early mortality has been due primarily 
to technical failures. Venous obstruction and the 
resultant pulmonary edema has been the most 
common cause of failure and decreased function. ' 
A high incidence of thrombosis occurs with 
anastomosis of individual pulmonary veins. For 
this reason, individual lobes are less frequently 
reimplanted, and the atrial cuff technique is 
utilized in most lungreimplantations. This method 
does not prevent venous obstruction entirely, 
however. Decreased function and pulmonary 
hypertension were found in lungs in which exci-
sion and reanastomosis of a cuff of atrium con-
taining the pulmonary veins were the only proce-
dures. 5 Acute thrombosis, chronic fibrotic narrow-
ing ofthe suture line, and fibrous plugs originating 
proximal to the anastomosis have been described. s1 
Thrombosis at the pulmonary artery anastomo-
sis has not been observed frequently except in the 
presence of vascular stasis in the lung secondary to 
narrowing of the venous anastomosis. A pressure 
gradient across the arterial anastomosis is often 
demonstrable and is more severe when the contra-
lateral pulmonary artery is occluded."" Veith has 
shown that this is due to the inability of the anas-
tomosis to dilate, and he has advocated the creation 
of a distensible anastomosis by spatulating the 
ends of the pulmonary artery or by use of a vein 
patch in the anastomosis.34 
Bronchial complications have been observed in 
as many as 50 per cent of animals undergoing 
reimplantation. ll Ischemia of the bronchial anas-
tomosis is the major cause. Stone,32 after division 
and reanastomosis of only the bronchus, found 
necrotic changes at most of the anastomoses. By 6 
weeks, however, the majority of these changes had 
regressed and healing was occurring. Subsequent 
scar tissue formation may narrow the bronchus, 
but this must be severe to be functionally signifi-
cant. Most investigators have found that if the 
bronchus is divided as close to the hilum as possi-
ble, the incidence of bronchial complications is 
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markedly reduced. 1. 19 Ellis14 has demonstrated 
that collateral blood flow via the pulmonary artery 
to the bronchus is present at the hilum but not 
more centrally. This would explain the lack of 
necrosis of the short bronchial stump. Others feel 
that reconstruction of the bronchial arterial supply 
is indispensable if bronchial complications are to 
be avoided. 23 
Division of hilar lymphatics has been found to 
have no effect, and regeneration of lymphatics is 
demonstrable within 2 to 3 weeks.19 
Functional Evaluation and 
Pathophysiology of the Reimplanted Lung 
Several methods have been employed to evalu-
ate function of the reimplanted lung. Differential 
bronchospirometry with measurement of ventila-
tion and oxygen uptake has been used most fre-
quently. Reliable separation of function of the 
reimplanted lung from that of the normal lung is 
difficult. Angiography has been used to evaluate 
circulation in the graft but gives little quantita-
tive information. Right heart catheterization is 
employed to measure cardiac output and pulmo-
nary vascular resistance. Balloon tamponade of 
the contralateral normal pulmonary artery and its 
effect on pulmonary resistance and cardiac dynam-
ics also may be accomplished by this method. 
Arterial blood gas determinations are used rou-
tinely to evaluate the status of the graft. The 
xenon-133 scintiscan is one of the most promising 
methods for evaluation of lung transplants. It is 
noninvasive, and sedation of the animal may not 
be required. Both ventilation and perfusion are 
evaluated in a quantitative fashion. 21 Oxygen up-
take and intrapulmonary shunts are not measured 
by this technique. The most stringent test of func-
tion has been simultaneous or delayed contra-
lateral pneumonectomy or pulmonary artery 
ligation. 
Function of the lung decreases immediately 
after reimplantation. Within 2 to 3 weeks the 
ventilation and oxygen uptake increase but do 
not return to normal in most instances.u,28 Per-
fusion of the graft is decreased also, especially to 
the upper lobe. However, in many instances ab-
normal vascular anastomoses are found in con-
junction with the decreased perfusion. 21 In those 
lungs without structural abnormalities, perfusion 
also will return toward normal. 
Pulmonary arterial hypertension is present to a 
variable degree in all reimplanted lungs, and is a 
major cause of death.2,25 Although hypertension 
decreases with time, the recovery phase is more 
prolonged, and pressure does not return to normal. 
Elevated pulmonary artery pressures may be 
secondary to arterial or venous stenosis, or vaso-
constriction of the pulmonary vascular bed. De-
pending on whether pressures are measured proxi-
mal or distal to the anastomosis, the true source of 
the pulmonary hypertension may be difficult to 
determine. Nigr025 demonstrated increased pulmo-
nary artery pressures in the absence of angio-
graphically demonstrable defects in the arterial or 
venous anastomoses. 
Pulmonary vascular resistance may be normal 
or increased. If the contralateral pulmonary 
artery is occluded or if contralateral reimplanta-
tion is done, resistance is usually elevated.24 Al-
though resistance is elevated, it is not fixed and 
will respond to infusions of acetylcholine with an 
improvement in oxygen uptake. Veith has demon-
strated that the vascular bed will dilate in re-
spOllse to oxygen following the vasoconstriction 
produced by hypoxia.33 
When simultaneous reimplantation and contra-
lateral pulmonary artery ligation are carried out, 
most animals die within 48 hours. The mechanism 
is acute pulmonary edema with right ventricular 
failure. s,24 Pulmonary artery pressures may in-
crease to three times the normal level. In normal 
dogs Daicoff has shown that occlusion of the right 
pulmonary artery causes a substantial increase in 
the left pulmonary artery pressure, suggesting 
that the capacity for pulmonary vasodilation is 
slight in the dog. R Factors other than increased 
capillary hydrostatic pressure may be involved in 
the production of pulmonary edema. Increased 
capillary permeability, decreased blood osmotic 
pressure, and obstructed lymphatic drainage have 
been implicated. 
The denervation of the lung that occurs as a 
consequence of reimplantation has been of serious 
concern to many investigators, as it was feared 
that respiratory paralysis would occur. It is gen-
erally recognized that the Hering-Breuer reflex is 
absent in reimplanted lungs, and regression of the 
intrinsic pulmonary nerves and afferent autonomic 
stretch receptors has been demonstrated. Denerva-
tion also has been postulated as an explanation for 
the increased vascular resistance. 
The fact that animals survive after bilateral re-
implantation or unilateral reimplantation with 
simultaneous contralateral pneumonectomy les-
sens the functional significance of denervation. 15 
The rate and rhythm of respiration in the resting 
state after these procedures usually are altered. 
More important, however, is the fact that these ani-
mals will respond normally to hypoxia and hyper-
carbia.30 In a dog studied 22 months after bilateral 
reimplantation, it was found that pulmonary 
function had continued to improve. Vagal block 
effected no change, indicating that regeneration 
had not occurred. Pulmonary hypertension also 
had shown progressive improvement, although a 
small gradient was present across the arterial 
anastomosis.29 
Immediate functional adequacy of the reim-
planted lung may be ascertained by occluding the 
contralateral pulmonary artery. It has been shown 
that arterial blood gas levels remain satisfactory 
and, although it is decreased, ventilatory function 
is adequate immediately after reimplantation. 3s 
Lung compliance either decreases or remains 
unchanged. Mucous transport has been studied, by 
means of tantalum particles, and found to be sub-
normal up to 120 days following reimplantation, 
but subsequently it became normal. This was 
ascribed to the effects of denervation."l 
Ischemia of the lung while reimplantation is 
